Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Alinity i Progesterone Reagent Kit

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall Alinity i Progesterone Reagent Kit see related information
Date Initiated by Firm November 21, 2018
Create Date December 22, 2018
Recall Status1 Terminated 3 on April 01, 2021
Recall Number Z-0668-2019
Recall Event ID 81632
Product Classification Radioimmunoassay, progesterone - Product Code JLS
Product Alinity i Progesterone Reagent Kit, List Number 08P3620
Code Information UDI/Lot Numbers (01)00380740121877 (17)190503(10) 91254UI00 / 91254UI00 (01)00380740121877 (17)190618(10)92360UI00 / 92360UI00 
Recalling Firm/
Manufacturer		 Abbott Ireland Diagnostics Division
Lisnamuck
Co. Longford Ireland
Manufacturer Reason
for Recall		 Abbott has become aware of a manufacturing issue that can result in damage to a bottle neck in some of the reagent cartridges found in the lots listed in Appendix A. If a bottle neck is damaged, it may cause a failure during the reagent loading process on the Alinity i instrument.
FDA Determined
Cause 2		 Nonconforming Material/Component
Action The firm initiated the recall by letter on 11/21/2018. The notice explained the problem and provided instruction on how to inspect the reagent cartridges for defect. The consignee was directed to discard the defective units. The units will be replaced.
Quantity in Commerce 157 units
Distribution AR, FL, GA, MD, OK, VA
Total Product Life Cycle TPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-